What is Pluto Bioinformatics?
Pluto Bioinformatics operates as a sophisticated, collaborative life sciences platform designed to re-envision the scientific research lifecycle. By providing a visually intuitive interface, the company enables organizations of varying sizes to manage complex research programs, track critical biomarkers, and monitor key results with unprecedented precision. The platform serves as a centralized hub for data management, facilitating secure information sharing and cross-functional collaboration. In an industry often hampered by fragmented data silos, Pluto offers a unified solution that streamlines workflows, thereby accelerating the pace of discovery and improving the reproducibility of scientific outcomes across diverse research environments.
How much funding has Pluto Bioinformatics raised?
Pluto Bioinformatics has raised a total of $8.3M across 3 funding rounds:
Angel/Seed
$1M
Angel/Seed
$3.7M
Unspecified
$3.6M
Angel/Seed (2021): $1M, investors not publicly disclosed
Angel/Seed (2023): $3.7M led by Silverton Partners
Unspecified (2025): $3.6M supported by Silverton Partners and Kickstarter
Key Investors in Pluto Bioinformatics
Silverton Partners
Silverton Partners is a leading early-stage venture capital firm based in Austin, Texas, specializing in investing in companies that leverage technology to create significant barriers to entry.
Kickstarter
Established in 2009, Kickstarter is an online crowdfunding platform and community that enables artists, musicians, filmmakers, designers, and other creators to raise funds for various community projects.
Undisclosed Investors
What's next for Pluto Bioinformatics?
With this latest capital injection, Pluto Bioinformatics is poised to accelerate its product development roadmap and expand its footprint within the global life sciences market. The strategic focus will likely center on enhancing the platform's analytical depth and integrating advanced data visualization tools to support increasingly complex research requirements. As the company transitions into a more mature enterprise-level entity, it will likely prioritize scaling its sales and customer success teams to meet the growing demand for integrated research management solutions. By leveraging its recent financing, Pluto aims to solidify its position as an essential utility for modern laboratories, ultimately driving efficiency and innovation in the pursuit of scientific breakthroughs.
See full Pluto Bioinformatics company page
